Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05482516
Title Evaluating Novel Therapies in ctDNA Positive GI Cancers (MRD-GI)
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Georgetown University
Indications

gastric adenocarcinoma

biliary tract cancer

hepatocellular carcinoma

gallbladder adenocarcinoma

colorectal adenocarcinoma

pancreatic adenocarcinoma

Therapies

Atezolizumab + Bevacizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.